Literature DB >> 19411368

Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder.

Diego A Pizzagalli1, Avram J Holmes, Daniel G Dillon, Elena L Goetz, Jeffrey L Birk, Ryan Bogdan, Darin D Dougherty, Dan V Iosifescu, Scott L Rauch, Maurizio Fava.   

Abstract

OBJECTIVE: Major depressive disorder is characterized by impaired reward processing, possibly due to dysfunction in the basal ganglia. However, few neuroimaging studies of depression have distinguished between anticipatory and consummatory phases of reward processing. Using functional MRI (fMRI) and a task that dissociates anticipatory and consummatory phases of reward processing, the authors tested the hypothesis that individuals with major depression would show reduced reward-related responses in basal ganglia structures.
METHOD: A monetary incentive delay task was presented to 30 unmedicated individuals with major depressive disorder and 31 healthy comparison subjects during fMRI scanning. Whole-brain analyses focused on neural responses to reward-predicting cues and rewarding outcomes (i.e., monetary gains). Secondary analyses focused on the relationship between anhedonic symptoms and basal ganglia volumes.
RESULTS: Relative to comparison subjects, participants with major depression showed significantly weaker responses to gains in the left nucleus accumbens and the caudate bilaterally. Group differences in these regions were specific to rewarding outcomes and did not generalize to neutral or negative outcomes, although relatively reduced responses to monetary penalties in the major depression group emerged in other caudate regions. By contrast, evidence for group differences during reward anticipation was weaker, although participants with major depression showed reduced activation to reward cues in a small sector of the left posterior putamen. In the major depression group, anhedonic symptoms and depression severity were associated with reduced caudate volume bilaterally.
CONCLUSIONS: These results suggest that basal ganglia dysfunction in major depression may affect the consummatory phase of reward processing. Additionally, morphometric results suggest that anhedonia in major depression is related to caudate volume.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19411368      PMCID: PMC2735451          DOI: 10.1176/appi.ajp.2008.08081201

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  35 in total

Review 1.  Multiple reward signals in the brain.

Authors:  W Schultz
Journal:  Nat Rev Neurosci       Date:  2000-12       Impact factor: 34.870

2.  Tracking the hemodynamic responses to reward and punishment in the striatum.

Authors:  M R Delgado; L E Nystrom; C Fissell; D C Noll; J A Fiez
Journal:  J Neurophysiol       Date:  2000-12       Impact factor: 2.714

3.  Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.

Authors:  Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale
Journal:  Neuron       Date:  2002-01-31       Impact factor: 17.173

4.  Dorsal striatum responses to reward and punishment: effects of valence and magnitude manipulations.

Authors:  M R Delgado; H M Locke; V A Stenger; J A Fiez
Journal:  Cogn Affect Behav Neurosci       Date:  2003-03       Impact factor: 3.282

5.  Predictability modulates human brain response to reward.

Authors:  G S Berns; S M McClure; G Pagnoni; P R Montague
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

6.  Individual differences in reinforcement learning: behavioral, electrophysiological, and neuroimaging correlates.

Authors:  Diane L Santesso; Daniel G Dillon; Jeffrey L Birk; Avram J Holmes; Elena Goetz; Ryan Bogdan; Diego A Pizzagalli
Journal:  Neuroimage       Date:  2008-07-02       Impact factor: 6.556

7.  Validation of hippocampal volumes measured using a manual method and two automated methods (FreeSurfer and IBASPM) in chronic major depressive disorder.

Authors:  Woo Suk Tae; Sam Soo Kim; Kang Uk Lee; Eui-Cheol Nam; Keun Woo Kim
Journal:  Neuroradiology       Date:  2008-04-15       Impact factor: 2.804

8.  Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression.

Authors:  Donald A Malone; Darin D Dougherty; Ali R Rezai; Linda L Carpenter; Gerhard M Friehs; Emad N Eskandar; Scott L Rauch; Steven A Rasmussen; Andre G Machado; Cynthia S Kubu; Audrey R Tyrka; Lawrence H Price; Paul H Stypulkowski; Jonathon E Giftakis; Mark T Rise; Paul F Malloy; Stephen P Salloway; Benjamin D Greenberg
Journal:  Biol Psychiatry       Date:  2008-10-08       Impact factor: 13.382

9.  Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward task.

Authors:  Diego A Pizzagalli; Dan Iosifescu; Lindsay A Hallett; Kyle G Ratner; Maurizio Fava
Journal:  J Psychiatr Res       Date:  2008-04-22       Impact factor: 4.791

10.  Modulation of caudate activity by action contingency.

Authors:  Elizabeth M Tricomi; Mauricio R Delgado; Julie A Fiez
Journal:  Neuron       Date:  2004-01-22       Impact factor: 17.173

View more
  426 in total

1.  Major depressive disorder is characterized by greater reward network activation to monetary than pleasant image rewards.

Authors:  Moria J Smoski; Alison Rittenberg; Gabriel S Dichter
Journal:  Psychiatry Res       Date:  2011-11-10       Impact factor: 3.222

2.  "I won, but I'm not getting my hopes up": depression moderates the relationship of outcomes and reward anticipation.

Authors:  Thomas M Olino; Dana L McMakin; Ronald E Dahl; Neal D Ryan; Jennifer S Silk; Boris Birmaher; David A Axelson; Erika E Forbes
Journal:  Psychiatry Res       Date:  2011-11-12       Impact factor: 3.222

Review 3.  Structural and synaptic plasticity in stress-related disorders.

Authors:  Daniel J Christoffel; Sam A Golden; Scott J Russo
Journal:  Rev Neurosci       Date:  2011       Impact factor: 4.353

Review 4.  Linking molecules to mood: new insight into the biology of depression.

Authors:  Vaishnav Krishnan; Eric J Nestler
Journal:  Am J Psychiatry       Date:  2010-09-15       Impact factor: 18.112

Review 5.  Reconsidering anhedonia in depression: lessons from translational neuroscience.

Authors:  Michael T Treadway; David H Zald
Journal:  Neurosci Biobehav Rev       Date:  2010-07-11       Impact factor: 8.989

6.  Social anhedonia in major depressive disorder: a symptom-specific neuroimaging approach.

Authors:  Verena Enneking; Pia Krüssel; Dario Zaremba; Katharina Dohm; Dominik Grotegerd; Katharina Förster; Susanne Meinert; Christian Bürger; Fanni Dzvonyar; Elisabeth J Leehr; Joscha Böhnlein; Jonathan Repple; Nils Opel; Nils R Winter; Tim Hahn; Ronny Redlich; Udo Dannlowski
Journal:  Neuropsychopharmacology       Date:  2018-11-27       Impact factor: 7.853

Review 7.  A systems neuroscience approach to the pathophysiology of pediatric mood and anxiety disorders.

Authors:  Wan-Ling Tseng; Ellen Leibenluft; Melissa A Brotman
Journal:  Curr Top Behav Neurosci       Date:  2014

Review 8.  A model for streamlining psychotherapy in the RDoC era: the example of 'Engage'.

Authors:  G S Alexopoulos; P Arean
Journal:  Mol Psychiatry       Date:  2013-11-26       Impact factor: 15.992

9.  Dopamine, depressive symptoms, and decision-making: the relationship between spontaneous eye blink rate and depressive symptoms predicts Iowa Gambling Task performance.

Authors:  Kaileigh A Byrne; Dominique D Norris; Darrell A Worthy
Journal:  Cogn Affect Behav Neurosci       Date:  2016-02       Impact factor: 3.282

10.  Individuals with more severe depression fail to sustain nucleus accumbens activity to preferred music over time.

Authors:  Lisanne M Jenkins; Kristy A Skerrett; Sophie R DelDonno; Víctor G Patrón; Kortni K Meyers; Scott Peltier; Jon-Kar Zubieta; Scott A Langenecker; Monica N Starkman
Journal:  Psychiatry Res Neuroimaging       Date:  2018-03-05       Impact factor: 2.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.